|
Market Cap (24-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 28 February 2023, 13:18. The announcement is marked as price sensitive, and is 27 page(s) in length and 838.3kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.006% short sold according to ASIC data. It was ranked the 594th most shorted stock on the ASX. It is now ranked as the 426th most shorted stock on the ASX with 0.138% of total shares short sold as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Half Yearly Report and Accounts | 28 February 2023, 13:18 |
| Regulatory approval for Phase II trial in France and Austria | 16 February 2023, 12:30 |
| Change in substantial holding | 15 February 2023, 8:03 |
| Notification of cessation of securities - ATH | 1 February 2023, 18:29 |
You must be logged in to post a reply.
Alterity Therapeutics 